Research programme: pseudomonas vaccine - GenVecAlternative Names: AdOprF.RGD.Epi8 - GenVec
Latest Information Update: 28 Feb 2008
At a glance
- Originator GenVec
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
Most Recent Events
- 24 Jun 2005 Preclinical trials in Pseudomonal infections in USA (unspecified route)
- 24 Jun 2005 Preclinical trials in Cystic fibrosis-associated respiratory tract infections in USA (unspecified route)